Welcome to Inside GRAPPA, a podcast and brought to you by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Our mission is to enhance understanding and treatment of psoriasis and psoriatic arthritis through the sharing of research, knowledge, and collaborative efforts.
We bring together leading rheumatologists, dermatologists, scientists, patient representatives, and industry partners, uniting our passions to make a difference for those living with these conditions.
Join our host Fabian Proft as we navigate the challenges, share the latest research, and explore the triumphs in the world of psoriasis and psoriatic arthritis. Together, we can make a difference.
Hosted on Acast. See acast.com/privacy for more information.
Welcome to Inside GRAPPA, a podcast and brought to you by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Our mission is to enhance understanding and treatment of psoriasis and psoriatic arthritis through the sharing of research, knowledge, and collaborative efforts.
We bring together leading rheumatologists, dermatologists, scientists, patient representatives, and industry partners, uniting our passions to make a difference for those living with these conditions.
Join our host Fabian Proft as we navigate the challenges, share the latest research, and explore the triumphs in the world of psoriasis and psoriatic arthritis. Together, we can make a difference.
Hosted on Acast. See acast.com/privacy for more information.
How does multimorbidity impact the progression from psoriasis to psoriatic arthritis? Can early identification of chronic conditions help prevent psoriatic arthritis in high-risk patients?
In this episode of Inside GRAPPA, host Dr. Mio Nakamura sits down with Dr. Paras Karmacharya, recipient of a GRAPPA Annual Pilot Research Grant. He presented his findings at the 2024 GRAPPA Annual in Seattle and shares his groundbreaking study with us on "Multimorbidity and Psoriasis as a Risk Factor for Psoriatic Arthritis." Dr. Karmacharya discusses his personal journey into psoriatic arthritis research, how his study leveraged the Rochester Epidemiology Project, and what the findings mean for the future of patient care. He also explores:
✔️ What multimorbidity really means in psoriatic disease
✔️ The connection between chronic conditions and psoriatic arthritis risk
✔️ How his study design helped uncover key insights
✔️ The clinical implications for screening, early intervention, and patient education
🔹 Multimorbidity matters: Patients with multiple chronic conditions at the time of psoriasis diagnosis had a significantly higher risk of developing psoriatic arthritis.
🔹 Psychiatric and musculoskeletal disorders---such as anxiety, mood disorders, and fibromyalgia---were strongly associated with increased risk.
🔹 A shift in clinical approach is needed: Multidisciplinary care models, early screening, and preventive strategies could improve patient outcomes.
📄 Learn more about GRAPPA's research initiatives: GRAPPA Website
🎧 Listen & subscribe to Inside GRAPPA on your favorite podcast platform.
Hosted on Acast. See acast.com/privacy for more information.
